|
|
|
Volumn , Issue 45, 1995, Pages 231-238
|
|
Ropinirole in the symptomatic treatment of Parkinson's disease
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DOPAMINE 2 RECEPTOR;
DOPAMINE RECEPTOR STIMULATING AGENT;
LEVODOPA;
ROPINIROLE;
ANTIPARKINSON AGENT;
INDOLE DERIVATIVE;
NEW DRUG;
ADULT;
AGED;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DYSKINESIA;
FEMALE;
HUMAN;
MALE;
NAUSEA;
PARKINSON DISEASE;
PRIORITY JOURNAL;
VOMITING;
DRUG COMBINATION;
PHASE 2 CLINICAL TRIAL;
REVIEW;
ANTIPARKINSON AGENTS;
CLINICAL TRIALS, PHASE II;
DOPAMINE AGONISTS;
DRUG THERAPY, COMBINATION;
DRUGS, INVESTIGATIONAL;
HUMANS;
INDOLES;
LEVODOPA;
PARKINSON DISEASE;
|
|
EID: 0028971356
PISSN: 03036995
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
|
Times cited : (68)
|
|
References (0)
|
